8-K current report · filed Jul 23, 2026

Organon & Co (OGN) 8-K Current Report: July 23, 2026

Item 5.07OGN overview

Short answer

Organon & Co (OGN) filed an 8-K current report with the SEC on July 23, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Merger agreement with Sun Pharma approved, clearing the key shareholder vote for Organon’s acquisition.

Organon & Co 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • Merger agreement with Sun Pharma approved, clearing the key shareholder vote for Organon’s acquisition
  • 192,776,552 votes for versus 2,573,118 against, representing strong approval among votes cast
  • 74.51% of voting power represented, exceeding the quorum requirement for the special meeting
  • Merger-related executive compensation approved on a non-binding basis, 185,141,986 votes for versus 9,553,830 against
  • Organon expected to become a wholly owned subsidiary of Sun Pharma USA upon merger completion

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Organon & Co 8-K filings

Get the next OGN 8-K as it lands

Follow OGN for push alerts, or ask the research agent what this filing means.